Benzophenones: Novel natural agents which inhibits HIV and Candida
二苯甲酮:抑制艾滋病毒和念珠菌的新型天然药物
基本信息
- 批准号:8071754
- 负责人:
- 金额:$ 12.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-29 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Acquired immunodeficiency syndrome (AIDS) is an immunosuppressive disease that results in life-threatening opportunistic infections and malignancies. Emphasis now has been placed on discovery and development of novel agents, including natural products, against viral and host factors involved in HIV transmission and infection, as well as therapeutics for opportunistic disease pathogens. Among these emerging therapies, natural products are receiving increased attention. Phytochemical investigations of the Rheedia brasiliensis' fruit resulted in the isolation and identification of new potentially bioactive benzophenones. The polyprenilated benzophenones have shown anti-microbial, anti-fungal and anti-HIV activity. However, the mechanism(s) of action of benzophenoes against both HIV and opportunistic infections, including Candida, has yet to be determined. The central objective is to identify the targets that mediate the activity of benzophenones on both HIV and the opportunistic microorganism Candida sp. and to identify the natural compounds with the highest therapeutic index. Mentored k99 phase: The mentored phase of the proposal will be carried out under the mentorship of Prof. Daniel Malamud and Prof. Simone Duarte at New York University. The goal of this phase is to evaluate the antiviral activity and toxicity of benzophenones on immortalized cell lines to establish the therapeutic index for both M-tropic and T-tropic strains of HIV-1; Aim 2) Identify and characterize specific molecular target(s) by which the benzophenones inhibit HIV infection through interaction with viral gp120 or mammalian cell receptors for the virus using circular dichroism, biosensor analysis and Aim 3) Evaluate and characterize the anti-fungal effect of benzophenones against C. albicans biofilms and determine how these agents affect the content and composition of the polysaccharide matrix, using a combination of fluorescence imaging techniques and Scanning Electron Microscopy. These studies will provide the structural data on modification of the biofilm matrix by the benzophenones, e.g. spatial distribution of biofilm matrix and fungi, and linkage composition of the polysaccharides. This training will provide expertise in virology, structure determination, and cell culture techniques. The acquired knowledge will provide the foundation for transition to an independent career. During the independent phase, I will continue my study with natural molecules to identify additional pathways that may contribute to prevent or treat infectious diseases and assess their potential in vivo.
PUBLIC HEALTH RELEVANCE: The development of novel agents derived from natural products that have the ability to inhibit both HIV and HIV-associated pathogens will have major impact on the HIV/AIDS epidemic, both in terms of developing new therapeutic agents, and demonstrating the unique activities of natural products with activity directed against multiple pathogens. The successful completion of the proposed studies has the potential to change the current strategies for dealing with both viral and microbial pandemics as well as promoting the value of therapeutic agents derived from natural products.
描述(申请人提供):获得性免疫缺陷综合症(艾滋病)是一种免疫抑制疾病,会导致危及生命的机会性感染和恶性肿瘤。现在的重点是发现和开发新的药物,包括天然产品,以对抗艾滋病毒传播和感染中涉及的病毒和宿主因素,以及治疗机会性疾病病原体的方法。在这些新兴疗法中,天然产品正受到越来越多的关注。通过对巴西大黄果实的植物化学研究,分离和鉴定了具有潜在生物活性的新的二苯甲酮类化合物。聚丙基二苯甲酮类化合物具有抗微生物、抗真菌和抗HIV活性。然而,二苯甲酚对艾滋病毒和包括念珠菌在内的机会性感染的作用机制(S)尚未确定。中心目标是确定介导二苯甲酮对艾滋病毒和机会微生物假丝酵母菌活性的靶标。并鉴定出治疗指数最高的天然化合物。指导K99阶段:计划的指导阶段将在纽约大学Daniel Malamud教授和Simone Duarte教授的指导下进行。此阶段的目标是评估二苯甲酮类化合物对永生化细胞株的抗病毒活性和毒性,以确立对M嗜性和T嗜性艾滋病毒1型毒株的治疗指数;目的2)利用圆二色谱、生物传感器分析和目标3)结合荧光成像技术和扫描电子显微镜,确定和表征二苯甲酮类化合物通过与病毒gp120或哺乳动物细胞受体相互作用抑制艾滋病毒感染的特异性分子靶点(S);目的3)评估和表征二苯甲酮类化合物对白色念珠菌生物被膜的抗真菌作用,并确定这些制剂如何影响多糖基质的含量和组成。这些研究将提供二苯甲酮类化合物修饰生物膜基质的结构数据,如生物膜基质和真菌的空间分布,以及多糖的连接组成。这项培训将提供病毒学、结构测定和细胞培养技术方面的专业知识。获得的知识将为过渡到独立的职业生涯奠定基础。在独立阶段,我将继续我对自然分子的研究,以确定可能有助于预防或治疗传染病的其他途径,并评估它们在体内的潜力。
与公共卫生相关:从能够抑制艾滋病毒和艾滋病毒相关病原体的天然产品中提取的新型制剂的开发将对艾滋病毒/艾滋病疫情产生重大影响,这既包括开发新的治疗剂,也表明天然产品具有针对多种病原体的独特活性。拟议研究的成功完成有可能改变目前应对病毒和微生物流行病的战略,并促进从天然产品中提取的治疗剂的价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ramiro Mendonca Murata其他文献
Ramiro Mendonca Murata的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ramiro Mendonca Murata', 18)}}的其他基金
Candida-Host interactions: impact on the host pro- and anti-viral restrictions factors
念珠菌-宿主相互作用:对宿主亲病毒和抗病毒限制因素的影响
- 批准号:
10477297 - 财政年份:2021
- 资助金额:
$ 12.49万 - 项目类别:
Candida-Host interactions: impact on the host pro- and anti-viral restrictions factors
念珠菌-宿主相互作用:对宿主亲病毒和抗病毒限制因素的影响
- 批准号:
10324146 - 财政年份:2021
- 资助金额:
$ 12.49万 - 项目类别:
Benzophenones: Novel natural agents which inhibits HIV and Candida
二苯甲酮:抑制艾滋病毒和念珠菌的新型天然药物
- 批准号:
8719942 - 财政年份:2010
- 资助金额:
$ 12.49万 - 项目类别:
Benzophenones: Novel natural agents which inhibits HIV and Candida
二苯甲酮:抑制艾滋病毒和念珠菌的新型天然药物
- 批准号:
8528915 - 财政年份:2010
- 资助金额:
$ 12.49万 - 项目类别:
Benzophenones: Novel natural agents which inhibits HIV and Candida
二苯甲酮:抑制艾滋病毒和念珠菌的新型天然药物
- 批准号:
8147031 - 财政年份:2010
- 资助金额:
$ 12.49万 - 项目类别:
Benzophenones: Novel natural agents which inhibits HIV and Candida
二苯甲酮:抑制艾滋病毒和念珠菌的新型天然药物
- 批准号:
8548230 - 财政年份:2010
- 资助金额:
$ 12.49万 - 项目类别:
相似国自然基金
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
- 批准号:82304677
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
- 批准号:82070530
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
- 批准号:32002421
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
- 批准号:31902347
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of novel tau-degrading molecular glue from artificial natural product extract by protein bead method
蛋白珠法从人工天然产物提取物中开发新型tau蛋白降解分子胶
- 批准号:
23K18191 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia
低强度超声的临床前测试作为预防化疗引起的脱发人源化小鼠模型中紫杉醇引起的毛囊损伤的新策略
- 批准号:
10722518 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
TET2 as a novel epigenetic regulator for uterine function and fertility
TET2 作为子宫功能和生育力的新型表观遗传调节因子
- 批准号:
10725828 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
Discovery and Development of a Benzoquinone Molecule as a Novel Anesthetic
苯醌分子作为新型麻醉剂的发现和开发
- 批准号:
10732956 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer
HLA-E 和 NKG2A 定义了非肌层浸润性膀胱癌的新型免疫检查点轴
- 批准号:
10587009 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
Novel therapies for obesity- or diabetes-related lymphatic dysfunction
肥胖或糖尿病相关淋巴功能障碍的新疗法
- 批准号:
10602589 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:
10701309 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
Novel mechanisms of microRNA-mediated anabolic effects in age-related osteoarthritis
microRNA介导的年龄相关骨关节炎合成代谢作用的新机制
- 批准号:
10663670 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 12.49万 - 项目类别: